Abstract
A series of forty-five derivatives of 3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and forty-five derivatives of 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones was synthesised. The compounds exhibited in-vitro activity against Mycobacterium tuberculosis, M. kansasii (two strains), and M. avium. The most active derivatives were more active than isonicotinhydrazide (INH). The quantitative relationships between the structure and antimycobacterial activity were calculated. The activity against M. tuberculosis increased with the lipophilicity of the substituents.
Similar content being viewed by others
References
Aaron, L., Saadoun, D., Calatroni, I., Launay, O., Mémain, N., Vincent, V., Marchal, G., Dupont, B., Bouchaud, O., Valeyre, D., & Lortholary, O. (2004). Tuberculosis in HIV-infected patients: a comprehensive review. Clinical Microbiology and Infection, 10, 388–398. DOI: 10.1111/j.1469-0691.2004.00758.x.
Dye, C. (2009). Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nature Reviews Microbiology, 7, 81–87. DOI: 10.1038/nrmicro2048.
Free, S. M., & Wilson, J. W. (1964). A mathematical contribution to structure-activity studies. Journal of Medicinal Chemistry, 7, 395–399. DOI: 10.1021/jm00334a001.
Fujita, T., & Ban, T. (1971). Structure-activity relation. 3. Structure-activity study of phenethylamines as substrates of biosynthetic enzymes of sympathetic transmitters. Journal of Medicinal Chemistry, 14, 148–152. DOI: 10.1021/jm00284a016.
Golbraikh, A., & Tropsha, A. (2002). Beware of q2! Journal of Molecular Graphics and Modelling, 20, 269–276. DOI: 10.1016/S1093-3263(01)00123-1.
Gupta, R. A., Gupta, A. K., Soni, L. K., & Kaskhedikar, S. G. (2009). Study of physicochemical properties-antitubercular activity relationship of naphtalene-1,4-dione analogs: A QSAR approach. Chemical Papers, 63, 723–730. DOI: 10.2478/s11696-009-0080-0.
Hansch, C., & Leo, A. J. (1979). Substituent constants for correlation analysis in chemistry and biology. New York, NY, USA: Wiley.
Hlasta, D. J., Demers, J. P, Foleno, B. D, Frago-Spano, S. A., Guan, J., Hilliar, J. J., Macielag, M. J., Ohemeng, K. A., Sheppard, C. M., Sui, Z., Webb, G. C., Weidner-Wells, M. A., Werblood, H., & Barrett, J. F. (1998). Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: Pharmacofore identification based on the screening hit closantel. Bioorganic & Medicinal Chemistry Letters, 8, 1923–1928. DOI: 10.1016/S0960-894X(98)00326-6.
Li, X., Liu, N., Zhang, H., Knudson, S. E., Slayden, R. A., & Tonge, P. J. (2010). Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: Novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters, 20, 6306–6309. DOI: 10.1016/j.bmcl.2010.08.076.
Macielag, M. J., Demers, J. P., Fraga-Spano, S. A., Hlasta, D. J., Johnson, S. G., Kanojia, R. M., Russell, R. K., Sui, Z., Weidner-Wells, M. A., Werblood, H., Foleno, B. D., Goldschmidt, R. M., Loeloff, M. J., Webb, G. C., & Barrett, J. F. (1998). Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria. Journal of Medicinal Chemistry, 41, 2939–2943. DOI: 10.1021/jm9803572.
Matyk, J., Waisser, K., Dražková, K., Kuneš, J., Klimešová, V., Palát, K., Jr., Kaustová, J. (2005). Heterocyclic isosters of antibacterial salicylanilides. II Farmaco, 60, 399–408. DOI: 10.1016/j.farmac.2005.02.002.
Naidoo, K., Naidoo, K., Padayatchi, N., & Karim, Q. A. (2011). HIV-associated tuberculosis. Clinical and Developmental Immunology, 2011, Article ID 585919, 8 pages. DOI: 10.1155/2011/585919.
Nemeček, P., Ďurčeková, T., Mocák, J., & Waisser, K. (2009). Chemometrical analysis of computed QSAR parameters and their use in biological activity prediction. Chemical Papers, 63, 84–91. DOI: 10.2478/s11696-008-0089-9.
O’Brien, R. J., & Nunn, P. P. (2001). The need for new drugs against tuberculosis. American Journal of Respiratory and Critical Care Medicine, 163, 1055–1058.
Petrlíková, E., Waisser, K., Jílek, P., & Dufková, I. (2010). Antibacterial activity of N-nenzylsalicylthioamides, Folia Microbiologica, 55, 418–421. DOI: 10.1007/s12223-010-0070-1.
Petrlíková E., Waisser K., Palát, K., Kuneš, J., Kaustová J. (2011). A new group of potential antituberculotics: N-(2-pyridylmethyl)salicylamides and N-(3-pyridylmethyl)salicylamides, Chemical Papers, 65, 52–59. DOI: 10.2478/s11696-010-0084-9.
Saeed, A., & Ashraf, Z. (2008). Synthesis of some 3-aryl-1H-isochromene-1-thiones. Journal of Heterocyclic Chemistry, 45, 679–682. DOI: 10.1002/jhet.5570450307.
Schroeder, E. K., de Souza, O. N., Santos, D. S., Blanchard, J. S., & Basso, L. A. (2002). Drugs that inhibit mycolic acid biosynthesis in mycobacterium tuberculosis. Current Pharmaceutical Biotechnology, 3, 197–225. DOI: 10.2174/1389201023378328.
Tortoli, E. (2009). Clinical manifestations of nontuberculous mycobacteria infections. Clinical Microbiology and Infection, 15, 906–910. DOI: 10.1111/j.1469-0691.2009.03014.x.
van den Boogaard, J., Kibiki, G. S., Kisanga, E. R., Boeree, M. J., & Aarnoutse, R. E. (2009). New drugs against tuberculosis: Problems, progress, and evaluation of agents in clinical development. Antimicrobial Agents and Chemotherapy, 53, 849–862. DOI: 10.1128/AAC.00749-08.
Wagner, G., Singer, D., & Weuffen, W. (1966). Studies on 2-hydroxythiobenzamide and 2-hydroxythiobenzanilide. 1. Synthesis of the compounds. Pharmazie, 21, 161–166.
Waisser, K., Čižmárik, J., Holý, P., Petrlíková, E., Kuneš, J., & Kaustová, J. (2009). Antimycobacterial 3-(4-ethoxythiocarbonylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-ethoxythiocarbonylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dithiones. Acta Facultatis Pharmaceuticae Universitatis Comenianae, 56, 171–179.
Waisser, K., Gregor, J., Kubicová, L., Klimešová, V., Kuneš, J., Macháček, M., & Kaustová, J. (2000). New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones. European Journal of Medicinal Chemistry, 35, 733–741. DOI: 10.1016/S0223-5234(00)00 174-4.
Waisser, K., Hladůvková, J., Holý, P., Macháček, M., Karajannis, P., Kubicová, L., Klimešová, V., Kuneš, J., & Kaustová, J. (2001a). 2H-1,3-benzoxazine-2,4(3H)-diones substituted in position 6 as antimycobacterial agents. Chemical Papers, 55, 323–334.
Waisser, K, Hladůvková, J, Kuneš, J, Kubicová, L, Klimešová, V, Karajannis, P, & Kaustová, J. (2001b). Synthesis and antimycobacterial activity of salicylanilides substituted in position 5. Chemical Papers, 55, 121–129.
Waisser, K., Matyk, J., Divišová, H., Husáková, P., Kuneš, J., Klimešová, V., Kaustová, J., Möllmann, U., Dahse, H.-M., & Miko, M. (2006). The oriented development of antituberculotics: Salicylanilides. Archiv der Pharmazie, 339, 616–620. DOI: 10.1002/ardp.200600093.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petrlíková, E., Waisser, K., Doležal, R. et al. Antimycobacterial 3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones substituted on phenyl and benzoxazine moiety in position 6. Chem. Pap. 65, 352–366 (2011). https://doi.org/10.2478/s11696-011-0020-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11696-011-0020-7